Moreover, several ALDH isoenzymes were associated to TICs properties, such as ALDH1A1 in melanoma and lung adenocarcinoma [20, 26], ALDH1B1 in colon cancer [27], ALDH1A3 in breast cancer and NSCLC [28, 29], and ALDH7A1 in prostate cancer [30]. This evidence concerns the gene ALDH1A3 and breast carcinoma.